Filter posts

My First Blog Entry: An Enlivened Biotech Industry and BIO International Convention

While Washington, DC struggles with yet another round of cold temperatures, inside the halls of …

BIO CEO Company Snapshot: Conatus Pharmaceuticals

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & …

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Is 2014 a good time to invest in biotech? How many biotech IPOs will there …

Lots of Buzz at the BIO Investor Forum

Thirty-eight biotech IPO’s this year. The NASDAQ Biotechnology Index is up 50 percent YTD.  Are …

Crowdfunding in Health Care and Biotechnology

Smaller private companies are constantly in search of capital, but many find it difficult to …

The New Road to IPO in the Age of the JOBS Act

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Successful Public-Private Partnerships

According to BayBio, biomedical companies that can harness the power of patient groups will get …

BIO Investor Forum Kicks Off Amid Industry Optimism

Today, the BIO Investor Forum kicks off in San Francisco, Calif. BioWorld’s Catherine Shaffer paints …

BIO Investor Forum to Showcase NSF-funded Companies

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at …